Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloid derived suppressor cells in chronic myeloid leukemia.
Giallongo C, Parrinello N, Brundo MV, Raccuia SA, Di Rosa M, La Cava P, Tibullo D. Giallongo C, et al. Among authors: la cava p. Front Oncol. 2015 May 15;5:107. doi: 10.3389/fonc.2015.00107. eCollection 2015. Front Oncol. 2015. PMID: 26029664 Free PMC article. Review.
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.
Giallongo C, Parrinello N, Tibullo D, La Cava P, Romano A, Chiarenza A, Barbagallo I, Palumbo GA, Stagno F, Vigneri P, Di Raimondo F. Giallongo C, et al. Among authors: la cava p. PLoS One. 2014 Jul 11;9(7):e101848. doi: 10.1371/journal.pone.0101848. eCollection 2014. PLoS One. 2014. PMID: 25014230 Free PMC article.
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.
Tibullo D, Di Rosa M, Giallongo C, La Cava P, Parrinello NL, Romano A, Conticello C, Brundo MV, Saccone S, Malaguarnera L, Di Raimondo F. Tibullo D, et al. Among authors: la cava p. Front Pharmacol. 2015 Oct 14;6:226. doi: 10.3389/fphar.2015.00226. eCollection 2015. Front Pharmacol. 2015. PMID: 26528182 Free PMC article.
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC).
Giallongo C, Tibullo D, Parrinello NL, La Cava P, Di Rosa M, Bramanti V, Di Raimondo C, Conticello C, Chiarenza A, Palumbo GA, Avola R, Romano A, Di Raimondo F. Giallongo C, et al. Among authors: la cava p. Oncotarget. 2016 Dec 27;7(52):85764-85775. doi: 10.18632/oncotarget.7969. Oncotarget. 2016. PMID: 26967390 Free PMC article.
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients.
Giallongo C, Romano A, Parrinello NL, La Cava P, Brundo MV, Bramanti V, Stagno F, Vigneri P, Chiarenza A, Palumbo GA, Tibullo D, Di Raimondo F. Giallongo C, et al. Among authors: la cava p. PLoS One. 2016 Jul 8;11(7):e0158392. doi: 10.1371/journal.pone.0158392. eCollection 2016. PLoS One. 2016. PMID: 27391078 Free PMC article.
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.
Romano A, Parrinello NL, Vetro C, Tibullo D, Giallongo C, La Cava P, Chiarenza A, Motta G, Caruso AL, Villari L, Tripodo C, Cosentino S, Ippolito M, Consoli U, Gallamini A, Pileri S, Di Raimondo F. Romano A, et al. Among authors: la cava p. Oncotarget. 2016 Oct 11;7(41):67333-67346. doi: 10.18632/oncotarget.12024. Oncotarget. 2016. PMID: 27637084 Free PMC article.
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma.
Romano A, Parrinello NL, Chiarenza A, Motta G, Tibullo D, Giallongo C, La Cava P, Camiolo G, Puglisi F, Palumbo GA, Di Raimondo F. Romano A, et al. Among authors: la cava p. Br J Haematol. 2019 May;185(3):468-479. doi: 10.1111/bjh.15801. Epub 2019 Feb 15. Br J Haematol. 2019. PMID: 30768678 Free article. Clinical Trial.
22 results